Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3804PDF: 733HTML: 1833 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13220PDF: 944HTML: 7276 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1070PDF: 733HTML: 194 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2218PDF: 817HTML: 2122New table Chinese children with APL: 151 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3091PDF: 1092HTML: 1729 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3537PDF: 853HTML: 6701 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2763PDF: 988HTML: 5506 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1771PDF: 788HTML: 10216Figures 1,2,3: 159 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
727PDF: 70HTML: 130 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2028PDF: 1626HTML: 349 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3447PDF: 858HTML: 1637figure 1: 151Untitled: 176 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2720PDF: 1092HTML: 3264 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2243PDF: 1310HTML: 17066Bassan Fig.1: 135Bassan Fig.2: 137Bassan Fig.4: 129Fig.3: 172 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1148PDF: 814HTML: 3347 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1199PDF: 578HTML: 213 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2786PDF: 1205HTML: 2679Figure 1: 155 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3328PDF: 1256HTML: 2201Fi.1 Gritti.Rambaldi: 192 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2147PDF: 925HTML: 2147 -
-
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2848PDF: 1332HTML: 3555Untitled: 181Untitled: 189Untitled: 167 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
977PDF: 359HTML: 82 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2774PDF: 829HTML: 6506Untitled: 213Untitled: 174Untitled: 183Untitled: 198 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4362PDF: 1593HTML: 3483Tables and Images: 202 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1652PDF: 789HTML: 925cover letter: 253
1 - 44 of 44 items







